BMRB Entry 4526
Click here to enlarge.
PDB ID: 1dc2
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR4526
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Yuan, C.; Selby, T.; Li, J.; Byeon, I.; Tsai, M.. "Tumor suppressor INK4: refinement of p16INK4A structure and determination of
p15INK4B structure by comparative modeling and NMR data" Protein Sci. 9, 1120-1128 (2000).
PubMed: 10892805
Assembly members:
CYCLIN-DEPENDENT KINASE 4 INHIBITOR A (P16INK4A), polymer, 156 residues, Formula weight is not available
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: PTG
Entity Sequences (FASTA):
CYCLIN-DEPENDENT KINASE 4 INHIBITOR A (P16INK4A): MEPAAGSSMEPSADWLATAA
ARGRVEEVRALLEAGALPNA
PNSYGRRPIQVMMMGSARVA
ELLLLHGAEPNCADPATLTR
PVHDAAREGFLDTLVVLHRA
GARLDVRDAWGRLPVDLAEE
LGHRDVARYLRAAAGGTRGS
NHARIDAAEGPSDIPD
- assigned_chemical_shifts
| Data type | Count |
| 13C chemical shifts | 242 |
Additional metadata:
Assembly:
| Entity Assembly ID | Entity Name | Entity ID |
|---|---|---|
| 1 | P16INK4A | 1 |
Entities:
Entity 1, P16INK4A 156 residues - Formula weight is not available
| 1 | MET | GLU | PRO | ALA | ALA | GLY | SER | SER | MET | GLU | ||||
| 2 | PRO | SER | ALA | ASP | TRP | LEU | ALA | THR | ALA | ALA | ||||
| 3 | ALA | ARG | GLY | ARG | VAL | GLU | GLU | VAL | ARG | ALA | ||||
| 4 | LEU | LEU | GLU | ALA | GLY | ALA | LEU | PRO | ASN | ALA | ||||
| 5 | PRO | ASN | SER | TYR | GLY | ARG | ARG | PRO | ILE | GLN | ||||
| 6 | VAL | MET | MET | MET | GLY | SER | ALA | ARG | VAL | ALA | ||||
| 7 | GLU | LEU | LEU | LEU | LEU | HIS | GLY | ALA | GLU | PRO | ||||
| 8 | ASN | CYS | ALA | ASP | PRO | ALA | THR | LEU | THR | ARG | ||||
| 9 | PRO | VAL | HIS | ASP | ALA | ALA | ARG | GLU | GLY | PHE | ||||
| 10 | LEU | ASP | THR | LEU | VAL | VAL | LEU | HIS | ARG | ALA | ||||
| 11 | GLY | ALA | ARG | LEU | ASP | VAL | ARG | ASP | ALA | TRP | ||||
| 12 | GLY | ARG | LEU | PRO | VAL | ASP | LEU | ALA | GLU | GLU | ||||
| 13 | LEU | GLY | HIS | ARG | ASP | VAL | ALA | ARG | TYR | LEU | ||||
| 14 | ARG | ALA | ALA | ALA | GLY | GLY | THR | ARG | GLY | SER | ||||
| 15 | ASN | HIS | ALA | ARG | ILE | ASP | ALA | ALA | GLU | GLY | ||||
| 16 | PRO | SER | ASP | ILE | PRO | ASP |